Natixis Advisors’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-26,314
Closed -$341K 1626
2025
Q1
$341K Buy
26,314
+3,778
+17% +$50K ﹤0.01% 1529
2024
Q4
$288K Buy
+22,536
New +$273K ﹤0.01% 1561
2024
Q1
Sell
-19,058
Closed -$266K 1543
2023
Q4
$266K Buy
19,058
+1,804
+10% +$25.1K ﹤0.01% 1486
2023
Q3
$255K Buy
+17,254
New +$243K ﹤0.01% 1458

Other funds holding DVAX

Natixis Advisors's DVAX Position: Q2 2025 in Review

Natixis Advisors sold out of Dynavax Technologies (DVAX) in Q2 2025, closing a stake of 26,314 shares — an estimated $341K sold.

Natixis Advisors first reported a position in DVAX in Q3 2023 and held it in 4 quarters. The position peaked at $341K in Q1 2025. 268 funds tracked by Wall St. Rank hold DVAX as of Q2 2025.

  • Natixis Advisors reported no remaining Dynavax Technologies position as of Q2 2025 after selling out during the quarter.
  • Natixis Advisors sold 26,314 Dynavax Technologies shares in Q2 2025, an estimated $341K.
  • Natixis Advisors first reported a position in Dynavax Technologies in Q3 2023 and held it in 4 quarters.
  • Natixis Advisors's Dynavax Technologies position peaked at $341K in Q1 2025.
  • 268 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2025.

Based on Natixis Advisors's 13F filing for Q2 2025, filed 13 Aug 2025.